ChargePoint Technology has announced the launch of ChargePoint Actis™, a breakthrough aseptic transfer system set to fundamentally change how pharmaceutical manufacturers achieve sterility assurance at one of the most critical risk points of aseptic processes. For the first time, ChargePoint Actis™ enables isolator-level regulatory confidence in a single compact system. As a result, it has the potential to transform Annex 1-aligned facility design, reduce infrastructure costs and accelerate processing.

Complete transfer confidence, without compromise

ChargePoint Actis™ introduces an entirely new level of confidence in aseptic transfer, combining proven principles – isolation, rapid transfer ports, split valves and steam sterilisation – into a single, compact, fully automated system. Traditionally, achieving sterility assurance at this point has required significant investment of capital, infrastructure, space and operational complexity, in order to manage a critical vulnerability where two transfer surfaces meet and separate: the ring of concern. High-grade cleanrooms, isolator barriers, laminar air flow systems and complex decontamination processes have been among the necessary compromises, until now. ChargePoint Actis™ is designed to bypass the ring of concern and eliminate reliance on additional infrastructure by building validated sterility assurance and both primary and secondary containment into the transfer connection itself.

The system enables direct aseptic transfer of material through a steam-sterilisable chamber without ever exposing product to the surrounding environment. This directly addresses multiple requirements for aseptic transfer outlined in EU GMP Annex 1, including closed-transfer, penetrative sterilisation for product contact surfaces, reduced manual handling and negated first air disruption. As a result, ChargePoint Actis™ supports the downgrade of cleanroom classifications and eliminates reliance on transfer process isolators, delivering meaningful savings in capital, floor space and operational costs while maintaining or strengthening compliance confidence. Furthermore, a single steam in place (SIP) sterilisation cycle supports multiple consecutive transfers. Combined with automated direct transfer that bypasses intermediate handling steps and manual intervention, this translates to faster and more efficient processing.

Designed for the future of pharmaceutical manufacturing

“ChargePoint Actis™ represents a quantum leap in aseptic processing,” comments Chris Eccles, CEO of ChargePoint Technology. “For years, pharmaceutical manufacturers have had to balance sterility assurance with operational complexity and cost. ChargePoint Actis™ changes that equation by integrating validated sterility directly into the transfer connection itself – without compromising on efficiency, expenditure or footprint. This is groundbreaking aseptic transfer technology designed and validated, not only for today’s manufacturing requirements, but for the future of Annex 1 compliance, advanced therapeutics and evolving aseptic processes.”

To find out more about ChargePoint Actis™ and what it makes possible for Annex 1-ready aseptic transfer, please visit: ChargePoint Actis™ is here.

For further details, contact:         

Amy Mesrie
Account Executive
BDB Global   
amy.mesrie@bdb.global    

Dawn Braithwaite
Marketing Campaign Manager
ChargePoint Technology
Dawn.Braithwaite@thechargepoint.com 

Ben Wiley
Head of Product Management and Marketing 
ChargePoint Technology
ben.wylie@thechargepoint.com 

About ChargePoint Technology

ChargePoint Technology is trusted a global specialist in powder transfer, flexible packaging and fluid management technologies. Its solutions help manufacturers protect their people, products and business impact, enabling the safe and reliable transfer and storage of both sensitive and highly potent materials in GMP manufacturing environments, containment and aseptic processing.

Headquartered in Liverpool, UK, ChargePoint’s portfolio includes high-containment and aseptic transfer technologies, alongside single-use technology and fluid storage and transport solutions designed to support safer and more efficient processing in the global pharmaceutical and biopharmaceutical industries and beyond. 

For more information, visit www.thechargepoint.com

Report Abuse